A study finds that people aged 20-30 years in the U.S. had the biggest increase in metastatic, early-onset colorectal cancer between 2000 and 2016, and that Blacks and Hispanics may have the highest risk.
The FDA approved the targeted immunotherapy tebentafusp-tebn for certain adult patients with uveal melanoma. The U.S. Food and Drug Administration (FDA) has approved tebentafusp-tebn (Kimmtrak), a fusion protein that acts as an immunotherapy, for...
Metastatic cancer patients nearing death continue to receive high-dose radiation despite guidelines advising against it, and new standards are likely to reduce racial disparities in lung cancer screening.
Each year in the United States, about 14,480 women are diagnosed with cervical cancer, and about 4,290 women die of the disease. Survivors often face a lifetime of complications, from infertility to pain and bleeding. ...
Cancer mortality continues to go down, and a “real-world” study finds more than a third of active surveillance patients are lost to follow-up.
Study investigates factors that contribute to cancer outcomes in a large and growing segment of the U.S. population.
Women with breast cancer who choose fertility preservation have treatment outcomes similar to women who don’t undergo fertility preservation.
Researchers aim to minimize disease relapses by targeting multiple proteins.
New interventions and therapies lead to a near doubling of survival of patients with acute lymphoblastic leukemia following relapse after transplants.
Three out of four people with advanced colorectal cancer suffer significant financial hardship, and lung cancer patients who quit smoking experience increased survival.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now